FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lukas Weigl

Research Profile

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Caterina Lacava; Andrea Michalek-Sauberer; Giampietro Sgaragli; Elisabeth Sipos; Fabio Fusi; Carmen Höller; Birgit Kraft; Hans Georg Kress; Lukas Weigl
3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Alexius Kaufmann; Birgit Kraft; Hans Georg Kress; Andrea Michalek-Sauberer; Ferdinand Steinboeck; Marta Weindlmayr; Lukas Weigl
Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
Alexius Kaufmann; Birgit Kraft; Andrea Michalek-Sauberer; Lukas Weigl
Novel ryanodine receptor mutation that may cause malignant hyperthermia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lukas Weigl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Caterina Lacava; Andrea Michalek-Sauberer; Giampietro Sgaragli; Elisabeth Sipos; Fabio Fusi; Carmen Höller; Birgit Kraft; Hans Georg Kress; Lukas Weigl
3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Pharmacological research : the official journal of the Italian Pharmacological Society 2012;66(1):80-7.
2012: Alexius Kaufmann; Birgit Kraft; Hans Georg Kress; Andrea Michalek-Sauberer; Ferdinand Steinboeck; Marta Weindlmayr; Lukas Weigl
Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
Anesthesia and analgesia 2012;114(5):1017-25.
2008: Alexius Kaufmann; Birgit Kraft; Andrea Michalek-Sauberer; Lukas Weigl
Novel ryanodine receptor mutation that may cause malignant hyperthermia.
Anesthesiology 2008;109(3):457-64.
2006: Christopher May; Lukas Weigl; Anton Karel; Martin Hohenegger
Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells.
Biochemical pharmacology 2006;71(10):1497-509.
2005: Julia Sacher; Lukas Weigl; Martin Werner; Csaba Szegedi; Martin Hohenegger
Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells.
The Journal of pharmacology and experimental therapeutics 2005;314(3):1032-41.
2004: Engelbert Deusch; Justus Benrath; Lukas Weigl; Konrad Neumann; Sibylle A Kozek-Langenecker
The mechanical properties of continuous spinal small-bore catheters.
Anesthesia and analgesia 2004;99(6):1844-7, table of contents.
2004: Sergej Milovic; Bibiane Steinecker-Frohnwieser; Wolfgang Schreibmayer; Lukas Weigl
The sensitivity of G protein-activated K+ channels toward halothane is essentially determined by the C terminus.
The Journal of biological chemistry 2004;279(33):34240-9.
2004: Lukas Weigl; Carmen Ludwig-Papst; Hans Georg Kress
4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.
Anesthesia and analgesia 2004;99(1):103-7.
2003: Engelbert Deusch; Birgit Kraft; Gabriele Nahlik; Lukas Weigl; Martin Hohenegger; Hans Georg Kress
No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes.
Journal of neuroimmunology 2003;141(1-2):99-103.
2003: Lukas Weigl; Andreas Zidar; Regina Gscheidlinger; Anton Karel; Martin Hohenegger
Store operated Ca2+ influx by selective depletion of ryanodine sensitive Ca2+ pools in primary human skeletal muscle cells.
Naunyn-Schmiedeberg's archives of pharmacology 2003;367(4):353-63.
2001: Lukas Weigl; Wolfgang Schreibmayer
G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics.
Molecular pharmacology 2001;60(2):282-9.
2000: Lukas Weigl; Martin Hohenegger; Hans Georg Kress
Dihydropyridine-induced Ca2+ release from ryanodine-sensitive Ca2+ pools in human skeletal muscle cells.
The Journal of physiology 2000;525 Pt 2():461-9.
1999: Martin Hohenegger; I Berg; Lukas Weigl; Georg W Mayr; Barry V L Potter; Andreas H Guse
Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytes.
British journal of pharmacology 1999;128(6):1235-40.